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WS12.1 Evidence of diminished FEV1 in CF 6-year-olds followed in
the European CF registry, 2007–2009
D.R. VanDevanter1, D.J. Pasta2. 1Case Western Reserve University School of
Medicine, Edgewood, United States; 2ICON Late Phase & Outcomes Research,
San Francisco, United States
Objectives: Studies have demonstrated that CF infants without respiratory signs and
symptoms commonly have lung disease markers including inﬂammation, bronchial
wall thickening, reduced ﬂow, and ventilation inhomogeneity. However, a majority
of CF 6-year-olds have an FEV1 >90% predicted, which might be considered
‘normal’ and suggest that only a minority of these children have diminished FEV1.
Methods: Stanojevic FEV1 % predicted and Z-score distributions were determined
for 686 6-year olds (362 males) from Austria, Belgium, Czech Republic, Germany,
Denmark, France, Greece, Hungary, Israel, Italy, The Netherlands, Portugal, and
Slovenia followed in the ECFS Registry. Observed Z-scores were plotted against
theoretical values based on the Normal distribution.
Conclusions: The population FEV1 % predicted was 91.6% (SD = 17.9). More
than twice as many children had FEV1 Z-scores <−1 than predicted for the
normative population (38.0% versus 15.9%), with a quarter fewer patients having
Z-scores >−1. Quantile-quantile plots revealed that FEV1 Z-scores were consis-
tently lower than expected, suggesting that most, if not all, CF children have
diminished lung function by age 6, including those patients with apparently ‘normal’
FEV1 % predicted values (Z-scores >−1). Strategies emphasizing treatment of the
minority of CF infants with respiratory signs and symptoms may be inadequate to
reduce lung disease progression in the population. Quantile-quantile plots may prove
useful for evaluating future population changes in CF lung disease progression.
WS12.2 The impact of switching to the new global lung function
initiative equations on spirometry results in the UK CF
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Background: The new Global Lung Function Initiative (GLI) all-age spirometry
reference equations have recently been endorsed by all international respiratory
societies, and are now considered the international gold standard (Quanjer et al; Eur
Resp J 2012, www.lungfunction.org). The UK CF Trust Registry wish to implement
these new equations shortly.
Aim: To predict the likely impact of the switch from the current Knudson equations
(Am Rev Resp Dis 1983) upon interpretation of annual spirometry measurements.
Methods: The GLI-2012 equations were applied to a subset of cross-sectional data
from Port CF (950 patients; 6−75 years) to calculate FEV1 and FVC as %predicted,
and compared with those calculated from Knudson.
Results: Group results were slightly but signiﬁcantly lower by GLI-2012 vs
Knudson (FEV1 −2.44%, (95% CI −2.29; −2.59) and FVC −4.02% (−3.83; −4.21).
Differences in FEV1 within individuals were far greater, ranging from −12% to 5%.
There was a marked age effect, with Knudson underestimating FEV1% predicted
in younger children and in adults above 50 years of age, but over-estimating in
adolescents, when compared with the rest of the population.
Conclusions: These ﬁndings demonstrate that the planned switch from Knudson
to GLI-2012 will result in minor changes in the population average, but could
markedly impact interpretation within an individual. The new reference values
should aid longitudinal tracking; allow valid interpretation of spirometry in young
children; and provide reassurance to older adults with CF. Importantly, they will
allow easier identiﬁcation of individuals with declining lung function during the
crucial adolescent years.
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Rationale and objectives: Prognostic assessment of adult CF patients has proven
difﬁcult. The 6 minute walk test (6MWT) provides prognostic information in various
respiratory diseases, but only limited data exist in adult CF patients.
Methods: A retrospective study in a single adult CF center in Paris (France). All
consecutive CF adults who performed a 6MWT over a 12 year period were analyzed.
Determinants of a low 6 minute walking distance (6MWD) or a desaturation
(SpO2 90% at any time during the 6MWT) were examined using multivariate
logistic regression analyses. Prognostic value of these variables was assessed by
Kaplan–Meier and Cox analyses.
Results: A 6MWT was performed in 286 CF adults (median age, 28 yr; median
FEV1, 45% predicted) of whom 40 (14%) had lung transplantation and 18 (6%)
died without transplantation during follow-up. Although the 6MWD correlated with
FEV1% predicted, it was markedly different in subjects within the same range of
airﬂow limitation. A 6MWD 475m was established to best predict death or lung
transplantation, using a receiver operating curve analysis. Desaturation during the
6MWT occurred in 29% of patients, exclusively in subjects with an FEV1 60%
predicted. Both a 6MWD 475m and a desaturation during the 6MWT were mostly
found in patients with FEV1 60% predicted and were independent predictors of
death or lung transplantation.
Conclusion: The 6MWT provides prognostic information in CF adults, and should
be performed routinely, especially in subjects with FEV160% predicted.
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Objectives: To examine the determinants of 6MWD and desaturation during the 6
minute walk test in CF adults.
Methods: A retrospective study in a single adult CF center in Paris (France). All
consecutive CF adults who performed a 6MWT over a 12 year period were analyzed
(n = 286 patients). Determinants of a low 6 minute walking distance (6MWD) or
a desaturation (SpO2 90% at any time during the 6MWT) were examined using
multivariate logistic regression analyses.
Results: The median [IQR] 6MWD was 526 [460; 584]m. The 6MWD correlated
with FEV1 % predicted (Pearson r = 0.43; P < 0.001 [PB1]); median 6MWD
were 574m, 522m and 458m in subjects with moderate, severe and very severe
airﬂow limitation, respectively. A low 6MWD (475m) was found in 84 (29%)
patients, including 39/66 (59%) patients with FEV1 <30% predicted, 33/129 (26%)
patients with 30% FEV1 < 60% predicted, and 12/91 (13%) patients with FEV1
60% predicted (P < 0.0001, chi-square test). In multivariate analysis, only FEV1
% predicted and SpO2 at rest were signiﬁcant predictors of 6MWD. Desaturation
during the 6MWT was found in 83 (29%) patients, exclusively in patients with
FEV1 60% predicted. In multivariate analysis, variables associated with desatura-
tion during the 6MWT were SpO2 at rest, FEV1 % predicted, residual volume/total
lung capacity, body mass index, and liver cirrhosis.
Conclusion: Low 6MWD and desaturation during the 6MWT occurred in CF pa-
tients with FEV1 60%. This study suggest that these variables explore different
aspects of the disease in CF adult.
